2026-04-29T06:45:19Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/162882024-11-29T08:47:36Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19609col_20.500.12105_16969

00925njm 22002777a 4500 dc Redondo, Esther author Rivero-Calle, Irene author Mascarós, Enrique author Ocaña, Daniel author Jimeno, Isabel author Gil, Ángel author Díaz-Maroto, José Luis author Linares, Manuel author Onieva-García, María Ángeles author González-Romo, Fernando author Yuste, Jose Enrique author Martinón-Torres, Federico author 2023-01-10 In the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Spain caused by prevalent respiratory pathogens, based on the available scientific evidence through extensive bibliographic review and expert opinion. The emergence of COVID-19 as an additional etiological cause of CAP, together with the rapid changes in the availability of vaccines and recommendations against SARS-CoV-2, justifies the need for an update. In addition, new conjugate vaccines of broader spectrum against pneumococcus, existing vaccines targeting influenza and pertussis or upcoming vaccines against respiratory syncytial virus (RSV) will be very useful prophylactic tools to diminish the burden of CAP and all of its derived complications. In this manuscript, we provide practical recommendations for adult vaccination against the pathogens mentioned above, including their contribution against antibiotic resistance. This guide is intended for the individual perspective of protection and not for vaccination policies, as we do not pretend to interfere with the official recommendations of any country. The use of vaccines is a realistic approach to fight these infections and ameliorate the impact of antimicrobial resistance. All of the recently available scientific evidence included in this review gives support to the indications established in this practical guide to reinforce the dissemination and implementation of these recommendations in routine clinical practice. Antibiotics (Basel). 2023 Jan 10;12(1):138. 2079-6382 http://hdl.handle.net/20.500.12105/16288 36671339 10.3390/antibiotics12010138 Antibiotics (Basel, Switzerland) COVID-19 SARS-CoV-2 vaccines VRS Antimicrobial resistance Community-acquired pneumonia Influenza vaccination Influenza vaccines Pertussis Pneumococcal conjugate vaccines Pneumococcal polysaccharide vaccine Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group